363 related articles for article (PubMed ID: 28577717)
1. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
[TBL] [Abstract][Full Text] [Related]
2. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
[TBL] [Abstract][Full Text] [Related]
3. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
[TBL] [Abstract][Full Text] [Related]
4. Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?
Klooster B; Rajeev R; Chrabaszcz S; Charlson J; Miura J; Bedi M; Gamblin TC; Johnston F; Turaga KK
J Surg Oncol; 2016 Jun; 113(7):823-7. PubMed ID: 27060344
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
[TBL] [Abstract][Full Text] [Related]
8. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
[TBL] [Abstract][Full Text] [Related]
9. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
10. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.
Stahl JM; Corso CD; Park HS; An Y; Rutter CE; Han D; Roberts KB
Eur J Surg Oncol; 2017 Jan; 43(1):168-174. PubMed ID: 27335080
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative.
Thalji SZ; Tsai S; Gamblin TC; Clarke C; Christians K; Charlson J; Ethun CG; Poultsides G; Grignol VP; Roggin KK; Votanopoulos K; Fields RC; Abbott DE; Cardona K; Mogal H;
J Surg Oncol; 2020 Jun; 121(7):1140-1147. PubMed ID: 32167587
[TBL] [Abstract][Full Text] [Related]
12. Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.
Nazzani S; Preisser F; Bandini M; Marchioni M; Tian Z; Soulières D; Montanari E; Ratti D; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Oncol; 2018 Sep; 1(4):346-351. PubMed ID: 31100257
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
[TBL] [Abstract][Full Text] [Related]
14. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
15. Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial.
Smith MJ; Ridgway PF; Catton CN; Cannell AJ; O'Sullivan B; Mikula LA; Jones JJ; Swallow CJ
Radiother Oncol; 2014 Jan; 110(1):165-71. PubMed ID: 24411227
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
[TBL] [Abstract][Full Text] [Related]
17. Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.
Malinka T; Nebrig M; Klein F; Pratschke J; Bahra M; Andreou A
BMC Surg; 2019 Jun; 19(1):61. PubMed ID: 31182086
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
Raoof M; Blakely AM; Melstrom LG; Lee B; Warner SG; Chung V; Singh G; Chen YJ; Fong Y
Cancer Med; 2019 Oct; 8(13):5881-5890. PubMed ID: 31414566
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in resectable synovial sarcoma.
Vining CC; Sinnamon AJ; Ecker BL; Kelz RR; Fraker DL; Roses RE; Karakousis GC
J Surg Oncol; 2017 Sep; 116(4):550-558. PubMed ID: 28580620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
